BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38494974)

  • 1. [Expression and clinical significance of NEK2 and EMT related molecules in oral squamous cell carcinoma].
    Ye TT; Chen WH; Pei J; Jia YX; Wu HY
    Shanghai Kou Qiang Yi Xue; 2023 Dec; 32(6):640-644. PubMed ID: 38494974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
    Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
    Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
    J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143.
    Su W; Hu H; Ding Q; Wang M; Zhu Y; Zhang Z; Geng Z; Lin S; Zhou P
    Cell Commun Signal; 2022 Jun; 20(1):87. PubMed ID: 35705994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
    Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
    Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
    Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
    Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
    Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition.
    Zang W; Liu J; Geng F; Liu D; Zhang S; Li Y; Pan Y
    PeerJ; 2022; 10():e12991. PubMed ID: 35223210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of β-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases.
    Balasundaram P; Singh MK; Dinda AK; Thakar A; Yadav R
    Diagn Pathol; 2014 Jul; 9():145. PubMed ID: 25047112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
    Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK
    J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
    Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression of E-cadherin, vimentin, β-catenin, transforming growth factor-β1 in oral squamous cell carcinomas].
    Zhang L; Lu Z; Yin C; Xia M; Xie S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Apr; 50(4):228-34. PubMed ID: 26081960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin.
    Min A; Xiong H; Wang W; Hu X; Wang C; Mao T; Yang L; Huang D; Xia K; Su T
    J Oral Pathol Med; 2020 Nov; 49(10):1019-1029. PubMed ID: 32740991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
    Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
    Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P120ctn may participate in epithelial-mesenchymal transition in OSCC.
    Zhong C; Zuo Z; Ji Q; Feng D
    Indian J Cancer; 2016; 53(1):20-4. PubMed ID: 27146732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma.
    Wangmo C; Charoen N; Jantharapattana K; Dechaphunkul A; Thongsuksai P
    Pathol Oncol Res; 2020 Jul; 26(3):1511-1518. PubMed ID: 31471883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tumor budding and its correlation with histomorphological prognostic markers in oral squamous cell carcinoma and its association with the epithelial-mesenchymal transition process.
    Yadav K; Singh T; Varma K; Bhargava M; Misra V
    Indian J Pathol Microbiol; 2023; 66(1):3-8. PubMed ID: 36656202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.